References: Antidyskinetic actions of amantadine in Parkinson’s disease: are benefits maintained in the long term?

653

Views

CrossRef citations to date

Altmetric

References

Blanchet PJ, Konitsiotis S, Chase TN. Amantadine reduces levodopa-induced dyskinesias in parkinsonian monkeys. Mov. Disord.13(5), 798–802 (1998).
PubMed Web of Science ®Google Scholar
Luginger E, Wenning GK, Bösch S, Poewe W. Beneficial effects of amantadine on L-DOPA-induced dyskinesias in Parkinson’s disease. Mov. Disord.15(5), 873–878 (2000).
PubMed Web of Science ®Google Scholar
Verhagen Metman L, Del Dotto P, van den Munckhof P, Fang J, Mouradian MM, Chase TN. Amantadine as treatment for dyskinesias and motor fluctuations in Parkinson’s disease. Neurology50(5), 1323–1326 (1998).
PubMed Web of Science ®Google Scholar
Metman LV, Del Dotto P, LePoole K, Konitsiotis S, Fang J, Chase TN. Amantadine for levodopa-induced dyskinesias: a 1-year follow-up study. Arch. Neurol.56(11), 1383–1386 (1999).
PubMed Web of Science ®Google Scholar
Wolf E, Seppi K, Katzenschlager R et al. Long-term antidyskinetic efficacy of amantadine in Parkinson’s disease. Mov. Disord. DOI: 10.1002/mds.23034 (2010) (Epub ahead of print).
Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Antidyskinetic actions of amantadine in Parkinson’s disease: are benefits maintained in the long term?

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Antidyskinetic actions of amantadine in Parkinson’s disease: are benefits maintained in the long term?

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date